Table 2.
Kulasingam 2003 [27] | Sanders 2003 [28] | Goldie 2004 [29] | Taira 2004 [32] | Kulasingam 2007 [39] | |
Primary screening | CC | CC | CC/LBC | CC | CC |
Compliance | 100% (50–100%) | 71% (60–80%) | 100% | - | By age |
Triage | CC | - | HPV DNA | - | - |
Cytology | |||||
Sens/Spe | 0.556(0.51–0.95)/ 0.957(0.80–0.97) | 0.51(0.40–0.80)/ 0.97(0.95–0.98) | 0.66(0.34–0.86)/ 0.97(0.88–0.99) |
- | 0.80(0.48–0.80)/ 0.95(0.90–0.99) |
Price | $45 ($61–$75) | $81($61–$101) | $15–$51 ($12–75) |
$58($29–$86) | |
HPV DNA | |||||
Sens/Spe | - | - | - | - | - |
Price | $49 ($30–$200) | ||||
Goldhaber-Fiebert 2008 [33] | Kim 2008 [31] | Coupe, de Melker 2009 [35] | Coupe, van Ginkel 2009 [36] | Kim 2009 [30] | |
Primary screening | CC/HPV DNA | CC | CC/HPV DNA | CC | CC |
Compliance | - | - | 80% | 80% (20/70%) | - |
Triage | HPV DNA/CC | HPV DNA (3y) | HPV DNA/CC | - | HPV DNA |
Cytology | |||||
Sens/Spe | 0.8(0.186–0.99)/0.95(0.87–0.996) | - | - | - | - |
Price | $30($6–$87) | ||||
HPV DNA | |||||
Sens/Spe | 0.83(0.70–0.85) / 0.93(0.79–0.94) | - | 0.94/1 | - | - |
Price | $55($14–$217) | ||||
Kim, Ortendahl 2009 [34] | Accetta 2010 [38] | Diaz 2010 [43] | Demarteau 2011 [41] | Burger 2012 [42] | |
Primary screening | CC/Combined | CC/HPV DNA | CC/Combined | CC | CC |
Compliance | 53% 1y, 17% 2y, 11% 3y, 15% 5y | 70.90% | - | 60% 3y (48%,1y-72%,5y) | 100% |
Triage | HPV DNA | HPV DNA/CC | HPV DNA | - | HPV DNA |
Cytology | |||||
Sens/Spe | 0.8/0.95 | 0.8/0.95 | 0.8/0.95 | 0.58–0.61 (0.46–0.73) | 0.8/0.95 |
Price | |||||
HPV DNA | |||||
Sens/Spe | 0.93/0.93 | 0.96/0.94 | 0.88/0.93 | - | 1/1 |
Price | |||||
Coupe 2012 [37] | Tully 2012 [40] | Berkhof 2013 [44] | |||
Primary screening | CC/HPV DNA | CC | CC/HPV DNA | ||
Compliance | 80% (40%) | - | - | ||
Triage | -/CC | - | - | ||
Cytology | |||||
Sens/Spe | - | 0.58–0.85/0.962–0.974 | - | ||
Price | €52.80 | ||||
HPV DNA | |||||
Sens/Spe | 0.94/0.97 | - | -/1 | ||
Price | €65.6 |
CC refers to the Pap smear test